Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New hope for tough pancreatic cancer: chemo before surgery may boost survival

NCT ID NCT07155629

First seen Oct 01, 2025 · Last updated May 23, 2026 · Updated 30 times

Summary

This study looks at whether giving chemotherapy before surgery helps people with left-sided pancreatic cancer live longer than having surgery right away. About 381 patients with resectable tumors will be randomly assigned to one of these two approaches. The goal is to see if the chemo-first strategy improves overall survival.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER RESECTABLE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Helsinki University Central Hospital

    Helsinki, 00290, Finland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Oulu University Hospital

    Oulu, 90220, Finland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.